Functional assessment of prefrontal lobes in patients with major depression disorder using a dual-mode technique of 3D-arterial spin labeling and 18F-fluorodeoxyglucose positron emission tomography/computed tomography

Fu,Chang; Shi,Dapeng; Gao,Yongju; Xu,Junling

doi:10.3892/etm.2017.4594

Functional assessment of prefrontal lobes in patients with major depression disorder using a dual-mode technique of 3D-arterial spin labeling and 18F-fluorodeoxyglucose positron emission tomography/computed tomography

Authors:
- Chang Fu
- Dapeng Shi
- Yongju Gao
- Junling Xu
View Affiliations

Affiliations: Department of Nuclear Medicine, Zhengzhou University People's Hospital, Zhengzhou, Henan 450000, P.R. China, Department of Radiology, Zhengzhou University People's Hospital, Zhengzhou, Henan 450000, P.R. China
Published online on: June 13, 2017 https://doi.org/10.3892/etm.2017.4594
Pages: 1058-1064
Copyright: © Fu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of this study was to explore the functions of cerebral blood perfusion and glucose metabolism in the prefrontal lobe of patients with major depression disorder (MDD), and to analyze the correlations between these functional changes and depressive symptoms. 3D‑arterial spin labeling (ASL) and 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) were successfully performed in 17 patients with MDD and 16 healthy controls in a resting state. The depressive symptoms of the patients were classified into seven factors and scored with the Hamilton Depression Rating Scale. Regional cerebral blood flow (CBF) values and standardized uptake values (SUV) of 18F‑FDG in the whole brain were respectively compared between the patients and healthy controls using a two‑sample t‑test, and the correlations between the CBF and SUV in the prefrontal cerebral regions with the patients' Hamilton scores were evaluated using Pearson correlation analysis. Decreased regional CBF was indicated in the bilateral middle and the right superior frontal gyri, and decreased regional SUV was indicated in the bilateral superior, middle and inferior frontal gyri in the MDD patients compared with the controls. Positive correlations were observed between CBF values and aggregate Hamilton scores in the left middle and right middle frontal gyri of the patients. Positive correlations were also observed between SUVs and aggregate Hamilton scores in the left middle and right middle frontal gyri. 18F‑FDG PET/CT was indicated to be more sensitive than 3D‑ASL in identifying the functional abnormalities in the prefrontal lobe. Decreased CBF and SUV in the prefrontal lobe were closely correlated with Hamilton score. The left middle frontal gyrus may be a key functional region in MDD.

View Figures

View References

1	Knutson B, Bhanji JP, Cooney RE, Atlas LY and Gotlib IH: Neural responses to monetary incentives in major depression. Biol Psychiatry. 63:686–692. 2008. View Article : Google Scholar : PubMed/NCBI
2	Adrien J: Neurobiological bases for the relation between sleep and depression. Sleep Med Rev. 6:341–351. 2002. View Article : Google Scholar : PubMed/NCBI
3	Macey PM, Woo MA, Kumar R, Cross RL and Harper RM: Relationship between obstructive sleep apnea severity and sleep, depression and anxiety symptoms in newly-diagnosed patients. PLoS One. 5:e102112010. View Article : Google Scholar : PubMed/NCBI
4	Kameyama M, Fukuda M, Yamagishi Y, Sato T, Uehara T, Ito M, Suto T and Mikuni M: Frontal lobe function in bipolar disorder: A multichannel near-infrared spectroscopy study. Neuroimage. 29:172–184. 2006. View Article : Google Scholar : PubMed/NCBI
5	Galazzo I Boscolo, Mattoli MV, Pizzini FB, De Vita E, Barnes A, Duncan JS, Jäger HR, Golay X, Bomanji JB, Koepp M, et al: Cerebral metabolism and perfusion in MR-negative individuals with refractory focal epilepsy assessed by simultaneous acquisition of (18)F-FDG PET and arterial spin labeling. Neuroimage Clin. 11:648–657. 2016. View Article : Google Scholar : PubMed/NCBI
6	Lee HS, Choo IH, Lee DY, Kim JW, Seo EH, Kim SG, Park SY, Shin JH, Kim KW and Woo JI: Frontal dysfunction underlies depression in mild cognitive impairment: A FDG-PET study. Psychiatry Investig. 7:208–214. 2010. View Article : Google Scholar : PubMed/NCBI
7	Lui S, Parkes LM, Huang X, Zou K, Chan RC, Yang H, Zou L, Li D, Tang H, Zhang T, et al: Depressive disorders: Focally altered cerebral perfusion measured with arterial spin-labeling MR imaging. Radiology. 251:476–484. 2009. View Article : Google Scholar : PubMed/NCBI
8	Mayberg HS, Brannan SK, Tekell JL, Silva JA, Mahurin RK, McGinnis S and Jerabek PA: Regional metabolic effects of fluoxetine in major depression: Serial changes and relationship to clinical response. Biol Psychiatry. 48:830–843. 2000. View Article : Google Scholar : PubMed/NCBI
9	Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry. 23:56–62. 1960. View Article : Google Scholar : PubMed/NCBI
10	Vasic N, Wolf ND, Grön G, Sosic-Vasic Z, Connemann BJ, Sambataro F, von Strombeck A, Lang D, Otte S, Dudek M and Wolf RC: Baseline brain perfusion and brain structure in patients with major depression: A multimodal magnetic resonance imaging study. J Psychiatry Neurosci. 40:412–421. 2015. View Article : Google Scholar : PubMed/NCBI
11	Graff-Guerrero A, González-Olvera J, Mendoza-Espinosa Y, Vaugier V and Garcı́a-Reyna JC: Correlation between cerebral blood flow and items of the Hamilton rating scale for depression in antidepressant-naive patients. J Affect Disord. 80:55–63. 2004. View Article : Google Scholar : PubMed/NCBI
12	Wu JC, Gillin JC, Buchsbaum MS, Schachat C, Darnall LA, Keator DB, Fallon JH and Bunney WE: Sleep deprivation PET correlations of Hamilton symptom improvement ratings with changes in relative glucose metabolism in patients with depression. J Affect Disord. 107:181–186. 2008. View Article : Google Scholar : PubMed/NCBI
13	American Psychiatric Association, . Diagnostic and statistical manual of mental disorders. 4th. Washington, DC: 2000
14	Maier W, Buller R, Philipp M and Heuser I: The Hamilton anxiety scale: Reliability, validity and sensitivity to change in anxiety and depressive disorders. J Affect Disord. 14:61–68. 1988. View Article : Google Scholar : PubMed/NCBI
15	Orosz A, Jann K, Federspiel A, Horn H, Höfle O, Dierks T, Wiest R, Strik W, Müller T and Walther S: Reduced cerebral blood flow within the default-mode network and within total gray matter in major depression. Brain Connect. 2:303–310. 2012. View Article : Google Scholar : PubMed/NCBI
16	Wei K, Xue HL, Guan YH, Zuo CT, Ge JJ, Zhang HY, Liu BJ, Cao YX, Dong JC and Du YJ: Analysis of glucose metabolism of (18)F-FDG in major depression patients using PET imaging: Correlation of salivary cortisol and α-amylase. Neurosci Lett. 629:52–57. 2016. View Article : Google Scholar : PubMed/NCBI
17	Clark L, Chamberlain SR and Sahakian BJ: Neurocognitive mechanisms in depression: Implications for treatment. Annu Rev Neurosci. 32:57–74. 2009. View Article : Google Scholar : PubMed/NCBI
18	Seminowicz D, Mayberg H, McIntosh A, Goldapple K, Kennedy S, Segal Z and Rafi-Tari S: Limbic-frontal circuitry in major depression: A path modeling metanalysis. Neuroimage. 22:409–418. 2004. View Article : Google Scholar : PubMed/NCBI
19	Nauta WJ: Neural associations of the frontal cortex. Acta Neurobiol Exp (Wars). 32:125–140. 1972.PubMed/NCBI
20	van Hoeij F, Keijsers R, Loffeld B, Dun G, Stadhouders P and Weusten B: Incidental colonic focal FDG uptake on PET/CT: Can the maximum standardized uptake value (SUVmax) guide us in the timing of colonoscopy? Eur J Nucl Med Mol Imaging. 42:66–71. 2015. View Article : Google Scholar : PubMed/NCBI
21	Vidorreta M, Wang Z, Rodríguez I, Pastor MA, Detre JA and Fernández-Seara MA: Comparison of 2D and 3D single-shot ASL perfusion fMRI sequences. Neuroimage. 66:662–671. 2013. View Article : Google Scholar : PubMed/NCBI
22	Towgood KJ, Pitkanen M, Kulasegaram R, Fradera A, Soni S, Sibtain N, Reed LJ, Bradbeer C, Barker GJ, Dunn JT, et al: Regional cerebral blood flow and FDG uptake in asymptomatic HIV-1 men. Hum Brain Mapp. 34:2484–2493. 2013. View Article : Google Scholar : PubMed/NCBI
23	Greicius MD, Flores BH, Menon V, Glover GH, Solvason HB, Kenna H, Reiss AL and Schatzberg AF: Resting-state functional connectivity in major depression: Abnormally increased contributions from subgenual cingulate cortex and thalamus. Biol Psychiatry. 62:429–437. 2007. View Article : Google Scholar : PubMed/NCBI
24	Lui S, Deng W, Huang X, Jiang L, Ma X, Chen H, Zhang T, Li X, Li D, Zou L, et al: Association of cerebral deficits with clinical symptoms in antipsychotic-naive first-episode schizophrenia: An optimized voxel-based morphometry and resting state functional connectivity study. Am J Psychiatry. 166:196–205. 2009. View Article : Google Scholar : PubMed/NCBI
25	Hamilton JP, Etkin A, Furman DJ, Lemus MG, Johnson RF and Gotlib IH: Functional neuroimaging of major depressive disorder: A meta-analysis and new integration of base line activation and neural response data. Am J Psychiatry. 169:693–703. 2012. View Article : Google Scholar : PubMed/NCBI
26	Nishi H, Sawamoto N, Namiki C, Yoshida H, Dinh HD, Ishizu K, Hashikawa K and Fukuyama H: Correlation between cognitive deficits and glucose hypometabolism in mild cognitive impairment. J Neuroimaging. 20:29–36. 2010. View Article : Google Scholar : PubMed/NCBI
27	Bench CJ, Friston KJ, Brown RG, Scott LC, Frackowiak RS and Dolan RJ: The anatomy of melancholia-focal abnormalities of cerebral blood flow in major depression. Psychol Med. 22:607–615. 1992. View Article : Google Scholar : PubMed/NCBI
28	Brody AL, Saxena S, Silverman DH, Alborzian S, Fairbanks LA, Phelps ME, Huang SC, Wu HM, Maidment K and Baxter LR Jr: Brain metabolic changes in major depressive disorder from pre-to post-treatment with paroxetine. Psychiatry Res. 91:127–139. 1999. View Article : Google Scholar : PubMed/NCBI
29	Kennedy SH, Evans KR, Krüger S, Mayberg HS, Meyer JH, McCann S, Arifuzzman AI, Houle S and Vaccarino FJ: Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. Am J Psychiatry. 158:899–905. 2001. View Article : Google Scholar : PubMed/NCBI
30	Kimbrell TA, Ketter TA, George MS, Little JT, Benson BE, Willis MW, Herscovitch P and Post RM: Regional cerebral glucose utilization in patients with a range of severities of unipolar depression. Biol Psychiatry. 51:237–252. 2002. View Article : Google Scholar : PubMed/NCBI
31	de Asis JM, Silbersweig DA, Pan H, Young RC and Stern E: Neuroimaging studies of fronto-limbic dysfunction in geriatric depression. Clin Neurosci Res. 2:324–330. 2003. View Article : Google Scholar